GB201106750D0
(en )
2011-06-01
Novel compounds
IL231536A
(en )
2016-09-29
Indazole-3-carboxamides , pharmaceutical compositions comprising them and their use in the treatment of diseases
IL222268A
(en )
2015-11-30
Substituted pyrrolo-pyridines, pharmaceutical compositions comprising them, combined compositions comprising them and their use in the manufacture of medicaments
IL232113A
(en )
2017-05-29
Boron-containing compounds, pharmaceutical compositions comprising them and uses thereof in inhibiting arginase
IL217224B
(en )
2018-02-28
Pyrazolopyrimidines, pharmaceutical compositions comprising them and uses thereof
EP2818543A4
(en )
2015-11-04
Bacillus, hyaluronic acid enzyme, and uses thereof
TN2012000414A1
(en )
2014-01-30
Forms of rifaximin and uses thereof
ZA201206062B
(en )
2014-04-30
Aminotetraline derivatives,pharmaceutical compositions containing them,and their use in therapy
GB201106743D0
(en )
2011-06-01
Novel compounds
IL235923A0
(en )
2015-01-29
Aminotriazolopyridine for use in the treatment of inflammation, and pharmaceutical compositions thereof
IL223463A
(en )
2016-12-29
Urea derivatives , pharmaceutical compositions comprising them and uses thereof
PL2721045T3
(en )
2017-11-30
Compositions, methods of synthesis and use of carbohydrate targeted agents
EP2599490A4
(en )
2014-01-08
Anti-fatigue composition, formulation and use thereof
IL223176A0
(en )
2013-02-03
Tamarind seed polysaccharide for use in the treatment of microbial infections
IL223254A0
(en )
2013-02-03
Use of diatomaceous earth in the pharmaceutical industry
UA112760C2
(en )
2016-10-25
THEOBROMIN IN COMBINATION WITH GUYPHENESINE FOR THE TREATMENT OF Cough
MY158112A
(en )
2016-08-30
Use of agomelatine in obtaining medicaments intended for the treatment of obsessive-compulsive disorder (ocd)
UA96649C2
(en )
2011-11-25
Use of glucosamine hydrochloride as frigoprotective agent
LT2699545T
(en )
2016-09-26
Novel amino-pyrroline derivatives, and use thereof in the prevention and/or treatment of metabolic syndrome
TN2014000484A1
(en )
2016-03-30
Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.
MX2012012509A
(en )
2012-12-05
Tapentadol for use in the treatment of irritable bowel syndrome.
UA61166U
(en )
2011-07-11
Use of glucosamine hydrochloride as antiamnestic and antihypoxic agent
UA92646C2
(en )
2010-11-25
use of derivatives of 2-oxoindoline-3-glyoxyl acid as agents with actoprotective action
UA96048C2
(en )
2011-09-26
Use of interleukin-1 receptor antagonist as an frigoprotective agent
UA98143C2
(en )
2012-04-25
Use of interleukin-1 receptor antagonist as anxiolytic agent